187 related articles for article (PubMed ID: 3929215)
1. [Activity of the amoxicillin-clavulanic acid (augmentin) combination on strains of hospital isolates].
Deforges L; Le Van Thoi J; Soussy CJ; Duval J
Pathol Biol (Paris); 1985 May; 33(5):301-8. PubMed ID: 3929215
[TBL] [Abstract][Full Text] [Related]
2. [Effect of a ticarcillin-clavulanic acid (timentin) combination on bacteria resistant to ticarcillin].
Rouhan D; Le Noc P; Robert J
Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):461-5. PubMed ID: 3937121
[TBL] [Abstract][Full Text] [Related]
3. [Sensitivity to clavulanic acid of Escherichia coli isolated at the Henri Mondor hospital in 1986 according to phenotypes of beta-lactam antibiotic resistance].
Soussy CJ; Le Van Thoi J; Duval J
Pathol Biol (Paris); 1988 May; 36(5):442-5. PubMed ID: 3043340
[TBL] [Abstract][Full Text] [Related]
4. [Urinary tract infections in children. Status in a pediatric hospital and sensitivity of bacterial strains to amoxycillin-clavulanic acid combination].
Cochat N; Barbe G; Boutin-Tranchant ME; Cochat P
Pediatrie; 1987; 42(4):309-14. PubMed ID: 3671031
[TBL] [Abstract][Full Text] [Related]
5. [Effect of the amoxicillin-gentamicin combination in the presence of clavulanic acid on 8 strains of amoxicillin-resistant bacteria].
Deforges L; Soussy CJ; Duval J
Pathol Biol (Paris); 1984 Jun; 32(5 Pt 2):496-500. PubMed ID: 6379567
[TBL] [Abstract][Full Text] [Related]
6. Comparative in vitro activity of amoxycillin/clavulanate (augmentin), ceftazidime and ceftriaxone against hospital strains of gram-negative and -positive bacteria.
Abd-Elalim Eltahawy AT; Khalaf RM
Chemioterapia; 1988 Apr; 7(2):75-8. PubMed ID: 3293818
[TBL] [Abstract][Full Text] [Related]
7. [Sensitivity to fosfomycin of bacteria isolated at the Pitié-Salpétrière Hospital in 1982 and 1983].
Bismuth R; Jarlier V; Nicolas MH; Nguyen J; Truffot C
Pathol Biol (Paris); 1984 Jun; 32(5 Pt 2):520-4. PubMed ID: 6431379
[TBL] [Abstract][Full Text] [Related]
8. [Combined antibacterial activity of clavulanic acid with amoxicillin and ampicillin against Gram-negative strains].
Mascellino MT; Prignano G; Lorenzi A; Iegri F; Martorano E; Catania S; Ginanni Corradini S
Boll Ist Sieroter Milan; 1984; 63(5):447-52. PubMed ID: 6335660
[TBL] [Abstract][Full Text] [Related]
9. [Antimicrobial activity of amoxicillin versus amoxicillin/clavulanic acids. In vitro study against S aureus, H influenzae and A baumanii strains].
Trucco O; Prado V; Garreaud C; Paya E
Rev Med Chil; 1993 Aug; 121(8):916-22. PubMed ID: 8296100
[TBL] [Abstract][Full Text] [Related]
10. [Preliminary evaluation of the sensitivity of selected bacteria to amoxicillin and augmentin in comparison with other antibiotics used to date].
Ruczkowska J; Dolna I
Przegl Lek; 1984; 41(4):321-4. PubMed ID: 6565294
[No Abstract] [Full Text] [Related]
11. Antimicrobial resistance of Gram-negative bacilli isolates from inpatients and outpatients at Yaounde Central Hospital, Cameroon.
Piéboji JG; Koulla-Shiro S; Ngassam P; Adiogo D; Njine T; Ndumbe P
Int J Infect Dis; 2004 May; 8(3):147-54. PubMed ID: 15109589
[TBL] [Abstract][Full Text] [Related]
12. [Effect of an amoxicillin-clavulanic acid combination on the aerobic fecal flora in children].
Borderon JC; Rastegar A; Rolland JC; Laugier J
Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):569-72. PubMed ID: 3937129
[TBL] [Abstract][Full Text] [Related]
13. Sensitivity to augmentin and cephalosporines of some bacterial strains isolated from hospitalized patients.
Debeleac L; Iancu A; Tudorache D; Iancu G
Rom J Intern Med; 1995; 33(3-4):227-35. PubMed ID: 8646195
[TBL] [Abstract][Full Text] [Related]
14. [Differences in sensitivity to Augmentin (and other antibiotics) of Staphylococcus aureus strains isolated from various specimens and patients from different clinics].
Ruczkowska J; Dolna I
Przegl Lek; 1990; 47(10):702-5. PubMed ID: 2089448
[TBL] [Abstract][Full Text] [Related]
15. [In vitro study of the effects of a ticarcillin-clavulanic acid combination on Pseudomonas aeruginosa as a function of resistant phenotypes].
Thabaut A; Meyran M
Pathol Biol (Paris); 1985 May; 33(5):408-11. PubMed ID: 3929218
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM
J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456
[TBL] [Abstract][Full Text] [Related]
17. Bacteriological investigations with beta-lactamase inhibitors.
Ullmann U
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Jun; 252(2):222-9. PubMed ID: 6289565
[TBL] [Abstract][Full Text] [Related]
18. In vitro evaluation of Augmentin by broth microdilution and disk diffusion susceptibility testing: regression analysis, tentative interpretive criteria, and quality control limits.
Fuchs PC; Barry AL; Thornsberry C; Gavan TL; Jones RN
Antimicrob Agents Chemother; 1983 Jul; 24(1):31-8. PubMed ID: 6625554
[TBL] [Abstract][Full Text] [Related]
19. [In vitro effect of ceftriaxone on hospital bacteria. Line of regression and critical values].
Cluzel M; Chanal M; Sirot D; Sirot J; Cluzel R
Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):473-6. PubMed ID: 3937122
[TBL] [Abstract][Full Text] [Related]
20. [In-vitro activity of cefonicid on hospital bacteria. Regression line and proposal for critical values].
Chanal M; Cluzel M; Sirot D; Joly B; Sirot J; Cluzel R
Pathol Biol (Paris); 1986 May; 34(5):385-9. PubMed ID: 3095773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
